Is MDA legal in Cyprus?
Also known as: sass, sally
- Legal status
- Controlled under the Narcotic Drugs and Psychotropic Substances Law of 1977 (Law No. 29/1977, as amended; Classes A/B/C). MDA is a Class A drug: Part I, Class A of the First Schedule to the Law as substituted by the Narcotic Drugs and Psychotropic Substances (Controlled Drugs) (Amending) Order of 2025, K.Δ.Π. 367/2025, published in Official Gazette No. 5985 on 5 December 2025 lists «3,4-methylenedioxyamphetamine», with the other names «MDA» and «Tenamfetamine». Under section 30 and the Third Schedule, possession carries up to 12 years' imprisonment, and possession with intent to supply, supply, production, import and export carry up to life imprisonment, in each case or a fine, or both; taking any controlled drug in any way is a section 10 offence carrying up to life imprisonment or a fine, or both, whatever its class.
- Consequences if caught
- MDA is controlled in Cyprus under the Narcotic Drugs and Psychotropic Substances Law of 1977 (Law No. 29/1977, as amended), as a Class A drug in Part I, Class A of the First Schedule to the Law as substituted by the Narcotic Drugs and Psychotropic Substances (Controlled Drugs) (Amending) Order of 2025, K.Δ.Π. 367/2025, published in Official Gazette No. 5985 on 5 December 2025. Section 30 and the Third Schedule set the penalties. Possessing a controlled drug, under section 6(2), carries up to 12 years' imprisonment for a Class A drug, 8 years for Class B and 4 years for Class C, or a fine, or both. Possessing one with intent to supply under section 6(3), producing or supplying it under section 5(2), and importing or exporting it under section 4(1) carry up to life imprisonment for Class A and Class B and up to 8 years for Class C, or a fine, or both. Section 10(δ) makes it an offence «να λαμβάνει με οποιοδήποτε τρόπο οποιοδήποτε ελεγχόμενο φάρμακο», to take any controlled drug in any way, and the general column of the Third Schedule sets life imprisonment or a fine, or both, for a section 10 offence whatever the class. The proviso to section 30(2) limits imprisonment to two years for a person convicted of an offence of use, possession or transport of a controlled drug for personal use who was under 25 when it was committed and has no previous conviction under the Law or its Regulations. Section 30A presumes, unless the person satisfies the court otherwise, that possession or transport was for supply at 30 g or more of cannabis or its derivatives, 10 g or more of prepared opium or prepared cocaine or their derivatives, or 20 g or more in solid form or 20 cubic centimetres or more in liquid form of any controlled drug, and that cultivation was for supply at three or more cannabis plants, twenty or more opium poppy plants or five or more coca plants. The Law provides no death sentence; the longest term in its Third Schedule is life imprisonment, and the EMCDDA's Cyprus Country Drug Report 2019 states that «a life term has never been imposed».
- If prescribed or medical
- MDA is printed in paragraph 6 of the Second Schedule to the 1979 Regulations as substituted by the Narcotic Drugs and Psychotropic Substances (Amending) Regulations of 1995, K.Δ.Π. 79/1995, published in the Official Gazette, Part III(I), No. 2963 of 24 March 1995, as «Methylendioxyamphetamine». Regulation 9(2) of the Narcotic Drugs and Psychotropic Substances Regulations of 1979 (K.Δ.Π. 160/1979) lets any person possess a drug in the Second or Third Schedule to those Regulations (the print reads «Δευτέρω και Τρίτω Πίνακι», Second and Third Schedule, which is read here as each of them) «διά χορήγησιν δι' ιατρικούς, οδοντιατρικούς ή κτηνιατρικούς σκοπούς συμφώνως προς τάς οδηγίας ιατρού, οδοντιάτρου ή κτηνιάτρου», with the accents of the polytonic print simplified, for administration for medical, dental or veterinary purposes in accordance with the directions of a doctor, dentist or veterinary surgeon, and regulation 2 defines a doctor as a person registered as one under the Registration of Doctors Law, so on the text read directions given only by a doctor registered outside Cyprus are not within regulation 9(2). The proviso to regulation 9(2) withdraws that protection from a person supplied on a doctor's prescription who was at the same time being supplied a controlled drug by another doctor, or on that doctor's prescription, and did not disclose it to the first before the supply or prescription, or where that person or anyone on his behalf made a declaration or statement, false in any particular, to obtain the supply or prescription. Regulation 9(2) lifts only the prohibition on possession in section 6(1) of the Law, which is the basis of the offence in section 6(2); it says nothing about obtaining, importing or supplying. Section 10(δ) of the Law, which makes taking any controlled drug in any way an offence, applies subject to section 32, a defence of lack of knowledge, and to Regulations made under section 8, and regulation 6(3) lets a person other than a doctor or dentist administer a Second or Third Schedule drug to a patient in accordance with a doctor's or dentist's directions. The same Order also prints «Methylenedioxyamphetamine» in paragraph 1 of the Fourth Schedule, whose heading cites regulations 10, 11, 12, 13, 14, 21 and 22. Regulation 9(2) names only the Second and Third Schedules and makes no exception for a drug that is also in the Fourth. Importing a controlled drug is prohibited by section 4(1) of the Law unless Regulations under section 8 exempt it or the Minister licenses it under section 4(2). Regulation 3(1) lifts sections 4(1) and 6(1) only for the preparations described in the First Schedule to the Regulations, which since K.Δ.Π. 105/2021 also covers certain nitrous oxide. K.Δ.Π. 105/2021 recites amending instruments published on 4 February 1986, 20 February 1987, 24 March 1995, 25 February 2000, 11 April 2003, 27 October 2011, 26 February 2016 and 17 May 2019. K.Δ.Π. 79/1995 replaced the First, Second, Third, Fourth, Sixth and Seventh Schedules, and the Second Schedule it printed no longer lists dextropropoxyphene, which K.Δ.Π. 19/1986 had added to paragraph 6 of the Second Schedule, so that substance now appears only in paragraph 3 of the First Schedule. K.Δ.Π. 19/1986 and K.Δ.Π. 37/1987 added entries to the Second Schedule and amended other Schedules but did not touch the Third. After K.Δ.Π. 79/1995, K.Δ.Π. 37/2000 amends only the Seventh Schedule, K.Δ.Π. 282/2003 adds nalbuphine to the Second Schedule and tramadol to the Third, deletes dihydrocodeine from the First, adds three substances to the Sixth and zolpidem to the Seventh, K.Δ.Π. 446/2011 adds tapentadol to the Third and to the Sixth, K.Δ.Π. 41/2016 adds remifentanil to the Second, K.Δ.Π. 160/2019 amends regulations 2, 11, 12 and 16, and K.Δ.Π. 105/2021 amends regulation 2 and the First Schedule; none of these later instruments removes an entry from the Second or Third Schedule. The CyLaw indexes for 2020 to 2026 list no later Regulations amending the 1979 Regulations.
- Documentation
- Part I of the First Schedule as substituted by K.Δ.Π. 367/2025 lists «3,4-methylenedioxyamphetamine», with the other names «MDA» and «Tenamfetamine». Its Greek name is printed as «Τεναμφεταμίνη». The Law is cited as Law 29/1977 because that is how the CyLaw consolidation and the Gazette print it; earlier text on this page gave it as 29(I)/1977. The CyLaw consolidation runs to Law 159(I)/2020, and K.Δ.Π. 367/2025 recites the Laws of 1977 to 2020. The First Schedule printed inside that consolidation is still the 1977 text and is not the list in force. This is stated as at K.Δ.Π. 367/2025, published on 5 December 2025. Paragraph 3 of that Order replaces the whole First Schedule and paragraph 4 revokes every earlier Controlled Drugs Order. It is the latest Controlled Drugs Order in the CyLaw index of regulatory administrative acts read on 4 October 2026, which lists acts published up to 25 September 2026, and section 3(2) of the Law lets the Council of Ministers amend the First Schedule by Order, so this does not rule out a later amendment.
- Narcotic Drugs and Psychotropic Substances Law of 1977 (Law 29/1977), CyLaw consolidation to Law 159(I)/2020, sections 2, 3, 4, 5, 6, 8, 10, 30, 30A and 32 and Third Schedule, read on 4 October 2026
- cylaw.org
- Narcotic Drugs and Psychotropic Substances (Controlled Drugs) (Amending) Order of 2025, K.Δ.Π. 367/2025, Official Gazette No. 5985, 5 December 2025, First Schedule Parts I to IV
- cylaw.org
- CyLaw index of regulatory administrative acts for 2026, read on 4 October 2026
- cylaw.org
- EMCDDA, Cyprus Country Drug Report 2019
- naac.org.cy
- Narcotic Drugs and Psychotropic Substances Regulations of 1979, K.Δ.Π. 160/1979, regulations 2, 3, 6 and 9
- cylaw.org
- Narcotic Drugs and Psychotropic Substances (Amending) Regulations of 1995, K.Δ.Π. 79/1995, Official Gazette Part III(I) No. 2963, 24 March 1995, Second and Fourth Schedules
- cylaw.org
- K.Δ.Π. 105/2021
- cylaw.org
- K.Δ.Π. 37/2000
- cylaw.org
- K.Δ.Π. 282/2003
- cylaw.org
- K.Δ.Π. 446/2011
- cylaw.org
- K.Δ.Π. 41/2016
- cylaw.org
- K.Δ.Π. 160/2019
- cylaw.org
- K.Δ.Π. 19/1986
- cylaw.org
- K.Δ.Π. 37/1987
- cylaw.org
- CyLaw index of regulatory administrative acts for 2020
- cylaw.org
- CyLaw index of regulatory administrative acts for 2021
- cylaw.org
- CyLaw index of regulatory administrative acts for 2022
- cylaw.org
- CyLaw index of regulatory administrative acts for 2023
- cylaw.org
- CyLaw index of regulatory administrative acts for 2024
- cylaw.org
- CyLaw index of regulatory administrative acts for 2025
- cylaw.org
Want to know if Cyprus changes its law on MDA?
Drug-law changes, court decisions and research, once a month.
Free. We email you once to confirm. Unsubscribe with one click.
Court records
We have not yet assessed whether court records are publicly available for this jurisdiction.
Other substances confirmed in Cyprus
Same substance, other countries
Drug laws and enforcement change and vary within a country. This is not legal advice. Always confirm with Cyprus’s embassy or official drug authority before traveling; penalties can be severe, including imprisonment.
Before you travel
Verify current rules with the destination country’s official drug authority and your own country’s embassy before traveling. Find the destination’s U.S. embassy & official country guidance →
Non-U.S. travelers: check your own government’s travel advisory and embassy.
If you’re detained or arrested abroad
Contact your own country’s embassy or consulate in the destination immediately, not the destination’s authorities. U.S. citizens: contact the nearest U.S. embassy/consulate and the U.S. State Department at +1-202-501-4444 (from abroad). If a U.S. citizen is arrested or detained abroad →
